Drug Safety Patent Fight: Avadel Sues US FDA Over Interpretation Of Xyrem REMS Patent Use Code

 
• By Brenda Sandburg
Narcolepsy
Avadel sues FDA over patent decision that will delay approval of its narcolepsy treatment • Source: Shutterstock

More from Archive

More from Pink Sheet